TG Therapeutics Announces Positive Results from the UNITY-NHL Ph

TGTX: TG Therapeutics, Inc.
2019-10-28 07:00:05
TG Therapeutics Announces Positive Results from the UNITY-NHL Phase 2b Pivotal Trial Evaluating Umbralisib Monotherapy in Patients with Relapsed/Refractory Follicular Lymphoma